John Wilson
Director/Board Member bei MARKER THERAPEUTICS, INC.
Vermögen: 7 Mio $ am 31.03.2024
Aktive Positionen von John Wilson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MARKER THERAPEUTICS, INC. | Director/Board Member | 17.10.2018 | - |
Independent Dir/Board Member | 17.10.2018 | - | |
Chief Executive Officer | - | - | |
Wilson Wolf Manufacturing Corp.
Wilson Wolf Manufacturing Corp. Medical SpecialtiesHealth Technology Wilson Wolf Manufacturing Corp. is a private company based in St. Paul, MN that was founded in 1998 by John R. Wilson, who has been the CEO since then. The company specializes in developing and manufacturing innovative cell culture technologies, with a focus on advancing the field of cell and gene therapy through its patented G-Rex® bioreactor technology. The G-Rex® product line has experienced an average annual sales growth rate of 50% over the last 5 years and is commonly used in every phase of cell and gene therapy manufacturing. In 2020, Wilson Wolf formed a joint venture with Bio-Techne and Fresenius-Kabi called ScaleReady to bring more capacity to advance the cell and gene therapy field. The company's patented products and protocols are used for numerous applications, including monoclonal antibody production, corneal transplants, porcine heart valve testing, mesenchymal cell production, and islet transplants for type 1 diabetes. The company's technology represents a paradigm shift in cell culture devices, resulting in a process for cell culture that is less costly and more effective. | Chief Executive Officer | 01.01.1998 | - |
Founder | 01.01.1998 | - |
Karriereverlauf von John Wilson
Ehemalige bekannte Positionen von John Wilson
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ALLOVIR, INC. | Director/Board Member | 01.01.2018 | 17.05.2022 |
Chief Executive Officer | 01.08.2013 | 01.01.2018 | |
Founder | 01.08.2013 | 17.05.2022 | |
Independent Dir/Board Member | 01.01.2018 | 17.05.2022 | |
Cellex Biosciences, Inc. | Corporate Officer/Principal | - | - |
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Marker Cell Therapy, Inc. develops clinical stage immuno-oncology therapies. The company is headquartered in New Brighton, MN. | Chief Executive Officer | - | - |
Founder | - | - |
Ausbildung von John Wilson
Hamline University | Undergraduate Degree |
University of Minnesota | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Chief Executive Officer | 4 |
Founder | 3 |
Director/Board Member | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
ALLOVIR, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Cellex Biosciences, Inc. | Distribution Services |
Wilson Wolf Manufacturing Corp.
Wilson Wolf Manufacturing Corp. Medical SpecialtiesHealth Technology Wilson Wolf Manufacturing Corp. is a private company based in St. Paul, MN that was founded in 1998 by John R. Wilson, who has been the CEO since then. The company specializes in developing and manufacturing innovative cell culture technologies, with a focus on advancing the field of cell and gene therapy through its patented G-Rex® bioreactor technology. The G-Rex® product line has experienced an average annual sales growth rate of 50% over the last 5 years and is commonly used in every phase of cell and gene therapy manufacturing. In 2020, Wilson Wolf formed a joint venture with Bio-Techne and Fresenius-Kabi called ScaleReady to bring more capacity to advance the cell and gene therapy field. The company's patented products and protocols are used for numerous applications, including monoclonal antibody production, corneal transplants, porcine heart valve testing, mesenchymal cell production, and islet transplants for type 1 diabetes. The company's technology represents a paradigm shift in cell culture devices, resulting in a process for cell culture that is less costly and more effective. | Health Technology |
Marker Cell Therapy, Inc.
Marker Cell Therapy, Inc. Miscellaneous Commercial ServicesCommercial Services Marker Cell Therapy, Inc. develops clinical stage immuno-oncology therapies. The company is headquartered in New Brighton, MN. | Commercial Services |
- Börse
- Insiders
- John Wilson
- Erfahrung